July 21st 2007

  Buy Issue 2760

Articles from this issue:

COVER STORY: The fifth battle domain - cyberspace

EDITORIAL: Democracy triumphs in East Timor

NATIONAL SECURITY: Terrorist risk is fast approaching critical

CANBERRA OBSERVED: Security nightmare for Australian authorities

HOUSING: Home ownership: the unattainable dream?

NATIONAL CENSUS: Making sense of the Census

MEDICAL SCIENCE: Cloning - dead as the Dodo?

VICTORIA: Medical suicide campaign gets underway

STRAWS IN THE WIND: The gangs of Melbourne / Global yawning / Still looking for Dreyfus / Victimhood / A ship without a rudder

TAIWAN: Divisive politics alienate Taiwanese

OPINION: Left-wing bid to discredit our Anzac tradition

POPULAR CULTURE: Video games overtaking movies and music

AS THE WORLD TURNS: Why do we dress children like miniature adults?

Science and the academic left (letter)

The Net and I (letter)

Swedish film defended (letter)

Terrorist doctor-killers? (letter)

CINEMA: Triumphing against all the odds - Amazing Grace


Books promotion page

Cloning - dead as the Dodo?

by Charles Francis, AM, QC, RFD

News Weekly, July 21, 2007
A scientific breakthrough in Japan will enable stem cells to be created without the need to clone and destroy human embryos, reports Charles Francis QC.

A week is a long time in politics, but stem-cell science is moving even faster than politics. On June 7, the journals Nature and Cell Stem Cell published three papers reporting on a simple method of turning mouse skin cells into "pluripotent" stem cells which function like embryonic stem-cells in that they can be turned into any kind of cell.

These stem cells were obtained without cloning or destroying embryos and without the use of eggs or sperm.

Shinya Yamanaka of Kyoto University, who pioneered the technology, described his work at an international conference on stem-cell research held in Cairns in June.

"It's easy, there's no magic," he said. He took a mouse skin cell and introduced four small proteins which reprogrammed the cell's nuclear DNA to make it pluripotent, like embryonic stem-cells. "Pluripotent" cells have the potential to grow into any kind of cell.

Cloning pointless

Yamanaka's work should take the wind out of the sails of the cloning industry, which has claimed the only way to get embryonic stem-cells exactly matching a patient is by cloning, because the cloned embryo is the patient's identical twin. But if an identical match can be achieved by Yamanaka's reprogramming of skin cells, cloning becomes pointless.

For years stem-cell researchers have sought to obtain embryonic stem-cells through nuclear transfer - transplanting an adult cell's nucleus into an egg emptied of its own nucleus, and then trying to trigger cell division to produce an embryo. Such cloning requires the donation of eggs from women - dangerous for the women - and is an expensive, difficult technique, even in animals. It has not been achieved with human cells.

By contrast, Yamanaka's work takes the research out of the arena of the cloning industry and into the field of molecular and cell biology where Australia has considerable expertise.

The Nature commentary, entitled "Simple switch turns cells embryonic", says: "The race is now on to apply the surprisingly straightforward procedure to human cells. ... The method is inviting. Whereas cloning with humans was limited by the number of available eggs and by a tricky technique that takes some six months to master, Yamanaka's method uses basic cells and can be accomplished with simple lab techniques."

Even Alan Trounson, ubiquitous spruiker for cloning and embryo experimentation, conceded: "This is great science. It takes us a big step closer to reprogramming adult cells."

Yamanaka was an orthopaedic surgeon before switching to research. With a small team early in 2004 Yamanaka worked up a list of 24 possible genes he thought were instrumental in cell programming.

Using retro-viruses to deliver the genes into mouse skin cells, Yamanaka and one of his students, Kazutoshi Takahashi, eventually narrowed the number down to four active genes that triggered the transformation.

That the process proved so straightforward surprised Yamanaka. Scientists assumed that reprogramming would require a complex arrangement of far more genes. "We were very surprised," he says. Nervous after the Hwang fraud debacle, Yamanaka had another researcher repeat Takahashi's work.

When he published his results in Cell Stem Cell in August 2006, he took the unusual step of including every bit of lab data in the supplementary section of his paper.

Although Yamanaka's laboratory is small and doesn't have access to the vast funds available in the USA, he hints they may have more breakthroughs in store: "I think that this year or next year we could see reprogramming in human cells. I really believe it could come from our lab."

Breakthroughs as achieved by Yamanaka are a strong indicator that we should not expend any funds on cloning and experimentation on human embryos.

There is continuing good news of promising results from adult stem-cells, and clinical trials and treatments with stem cells from umbilical-cord blood, which is safely and painlessly collected after the birth of a baby.

Cord blood stem-cells are already used to treat leukaemia and other blood diseases, but scientists are also researching the use of these cells in the treatment of heart, liver and pancreatic diseases.

US trial

Particularly promising is a trial in the US in which children with Type 1 diabetes were treated with their own cord blood. It lowered their glucose levels and reduced their need for insulin.

Not only should we avoid unethical and destructive experiments with human cloning, but any Australian punter would advise politicians not to put taxpayers' money on horses with poor, or no, performance. Stick with the winners - who, incidentally, happen also to be ethical.

- Charles Francis, AM QC RFD, is a retired Melbourne lawyer and former Victorian state MP.

All you need to know about
the wider impact of transgenderism on society.
TRANSGENDER: one shade of grey, 353pp, $39.99

Join email list

Join e-newsletter list

Your cart has 0 items

Subscribe to NewsWeekly

Research Papers

Trending articles

NATIONAL AFFAIRS Cardinal Pell's appeal in the High Court this week

COVER STORY Beyond the Great Divide

NATIONAL AFFAIRS Time and timing are crucial to Cardinal Pell's appeal by Peter Westmore

COVER STORY Murray River full; reservoirs low; farms for sale ...

ILLICIT DRUGS Cannabis marketed to children in Colorado

EDITORIAL Holden, China, covid19: Time for industry reset

COVER STORY The world has changed: Now for the new order

© Copyright NewsWeekly.com.au 2017
Last Modified:
April 4, 2018, 6:45 pm